A Safety Study of the CARILLON® Mitral Contour
System™
for the Treatment of Mitral Regurgitation
Mitral regurgitation ("MR") is caused by various mechanisms related to structural or functional abnormalities of the mitral apparatus, adjacent myocardium, or both. Functional mitral regurgitation ("FMR") results from dilation of the mitral annulus and left ventricle leading to chordal tethering and resulting inadequate leaflet coaptation. With minimally invasive technologies generating groundbreaking clinical trial data, hemodynamic and functional data are now available to characterize the significance of treating FMR. Cardiac Dimensions has designed an implantable device with the goal of reducing mitral regurgitation using a simple percutaneous procedure – the CARILLON® Mitral Contour System™.
The CARILLON implant is a fixed length, double anchor device designed
to plicate the tissue next to the mitral valve annulus during the deployment
process.
CARILLON Mitral Contour System and Procedure Overview
Access / Introduction of Device
In this non-surgical procedure, a catheter is threaded into the heart via the jugular vein.
Catheter Placement
The catheter is guided to a vein that is adjacent to the mitral valve.
CARILLON Implant Placement
The CARILLON Implant is secured and released in the optimal location.
Watch the entire procedure in the following animation:
